February 18th, 2017
Our guest was Ima Garcia from Bristol-Myers Squibb (BMS) who shared with us information regarding EMPLICITI™ (elotuzumab), an immune therapy used in combination with lenalidomide and dexamethasone for previously treated patients with myeloma.
January 17th, 2017
Dr. Wilson Gonsalves, Hematologist and Multiple Myeloma specialist from Mayo Clinic, provided updates from the American Society of Hematology meeting held in December. He presented valuable information about transplant, current combination therapies and some ‘up-and-coming’ drugs. I want to thank Dr. Gonsalves, on behalf of the group as well as myself, for sharing part of his Saturday with us.